M&A TRANSACTION · 2019
21st Century Oncology, Inc. acquired by GenesisCare
$1.10B· 9.2x EBITDA
Target
21st Century Oncology, Inc.
Acquirer
GenesisCare
Strategic buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$120.0M
Deal Value
$1.10B
EV/EBITDA
9.2x
Context
This $1.10B acquisition of 21st Century Oncology, Inc. by GenesisCare sits in the medical practice specialty sub-vertical. The 9.2x EBITDA multiple paid in 2019 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. GenesisCare is acquiring as a strategic buyer; see how strategic acquirers typically price medical practice specialty businesses on our Medical Practice Specialty strategic buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the 21st Century Oncology, Inc. acquisition.